Paul Harold Johnson serves as Executive at LIFECORE BIOMEDICAL, INC. \DE\, where they oversee executive responsibilities. Since joining the company, Paul Harold Johnson has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 15, 2025 involved receiving (via award) 19,506 shares valued at $0.
Paul Harold Johnson currently holds 44,060 shares of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Harold Johnson has been a net neutral trader of LFCR stock. They have purchased $0 and sold $0 worth of shares.
Paul Harold Johnson's most recent insider trade was on Jul 15, 2025, when they sold 19,506 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |